The essential role of ERK in 4-oxo-2-nonenal-mediated cytotoxicity in SH-SY5Y human neuroblastoma cells

Journal of Neurochemistry

Volumn 108, Issue 6, 2009, Pages 1434-1441

  Lee, Hyun Pil ^a   Zhu, Xiaochun ^b   Zhu, Xiongwei ^a   Skidmore, S Chad ^b   Perry, George ^a,c   Sayre, Lawrence M ^b   Smith, Mark A ^a   Lee, Hyoung Gon ^a,b  

^a CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b CASE WESTERN RESERVE UNIVERSITY   (United States)

^c University of San Antonio   (United States)

Author keywords

4 hydroxynonenal; 4 oxo 2 nonenal; Cytotoxicity; Lipid peroxidation; Mitogen activated protein kinase; Neurodegeneration; Oxidative stress; Protein modification

Indexed keywords

4 OXO 2 NONENAL; FATTY ACID DERIVATIVE; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; MITOGEN ACTIVATED PROTEIN KINASE KINASE; MITOGEN ACTIVATED PROTEIN KINASE P38; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; CELL DEATH; CELL STRESS; CONTROLLED STUDY; CYTOTOXICITY; DRUG MECHANISM; ENZYME DEGRADATION; ENZYME INHIBITION; ENZYME PHOSPHORYLATION; HUMAN; HUMAN CELL; NEUROBLASTOMA CELL; NEUROPROTECTION; PRIORITY JOURNAL; PROTEIN FUNCTION; SIGNAL TRANSDUCTION;

ALDEHYDES; CELL DEATH; CELL LINE, TUMOR; COLLAGEN TYPE XI; ENZYME ACTIVATION; ENZYME INHIBITORS; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; HUMANS; L-LACTATE DEHYDROGENASE; MAP KINASE KINASE 4; NEUROBLASTOMA; TIME FACTORS; TUMOR SUPPRESSOR PROTEIN P53;

EID: 61349123614     PISSN: 00223042     EISSN: 14714159     Source Type: Journal    
DOI: 10.1111/j.1471-4159.2009.05883.x     Document Type: Article

References (47)

1. Alkhalaf M. Jaffal S. (2006) Potent antiproliferative effects of resveratrol on human osteosarcoma SJSA1 cells: novel cellular mechanisms involving the ERKs/p53 cascade. Free Radic. Biol. Med. 41, 318 325.
2. Arany I., Megyesi J. K., Kaneto H., Tanaka S. Safirstein R. L. (2004) Activation of ERK or inhibition of JNK ameliorates H(2)O(2) cytotoxicity in mouse renal proximal tubule cells. Kidney Int. 65, 1231 1239.
3. Bhat N. R. Zhang P. (1999) Hydrogen peroxide activation of multiple mitogen-activated protein kinases in an oligodendrocyte cell line: role of extracellular signal-regulated kinase in hydrogen peroxide-induced cell death. J. Neurochem. 72, 112 119.
4. Brand A., Gil S., Seger R. Yavin E. (2001) Lipid constituents in oligodendroglial cells alter susceptibility to H2O2-induced apoptotic cell death via ERK activation. J. Neurochem. 76, 910 918.
5. Camandola S., Poli G. Mattson M. P. (2000) The lipid peroxidation product 4-hydroxy-2,3-nonenal increases AP-1-binding activity through caspase activation in neurons. J. Neurochem. 74, 159 168.
6. Chang L. Karin M. (2001) Mammalian MAP kinase signalling cascades. Nature 410, 37 40.
7. Chu C. T., Levinthal D. J., Kulich S. M., Chalovich E. M. DeFranco D. B. (2004) Oxidative neuronal injury. The dark side of ERK1/2. Eur. J. Biochem. 271, 2060 2066.
8. Cobb M. H. (1999) MAP kinase pathways. Prog. Biophys. Mol. Biol. 71, 479 500.
9. Doorn J. A. Petersen D. R. (2002) Covalent modification of amino acid nucleophiles by the lipid peroxidation products 4-hydroxy-2-nonenal and 4-oxo-2-nonenal. Chem. Res. Toxicol. 15, 1445 1450.
10. Esterbauer H., Schaur R. J. Zollner H. (1991) Chemistry and biochemistry of 4-hydroxynonenal, malonaldehyde and related aldehydes. Free Radic. Biol. Med. 11, 81 128.
11. Facchinetti F., Dawson V. L. Dawson T. M. (1998) Free radicals as mediators of neuronal injury. Cell. Mol. Neurobiol. 18, 667 682.
12. Favata M. F., Horiuchi K. Y., Manos E. J. et al. (1998) Identification of a novel inhibitor of mitogen-activated protein kinase kinase. J. Biol. Chem. 273, 18623 18632.
13. Halliwell B., Gutteridge J. M. Cross C. E. (1992) Free radicals, antioxidants, and human disease: where are we now? J. Lab. Clin. Med. 119, 598 620.
14. Ishikawa Y. Kitamura M. (2000) Anti-apoptotic effect of quercetin: intervention in the JNK- and ERK-mediated apoptotic pathways. Kidney Int. 58, 1078 1087.
15. 2-induced ERK and Src kinase activity in human neuroblastoma cells. Neuroreport 13, 1057 1061.
16. Lambert P. F., Kashanchi F., Radonovich M. F., Shiekhattar R. Brady J. N. (1998) Phosphorylation of p53 serine 15 increases interaction with CBP. J. Biol. Chem. 273, 33048 33053.
17. Lee S. H. Blair I. A. (2000) Characterization of 4-oxo-2-nonenal as a novel product of lipid peroxidation. Chem. Res. Toxicol. 13, 698 702.
18. Lee S. H. Blair I. A. (2001) Oxidative DNA damage and cardiovascular disease. Trends Cardiovasc. Med. 11, 148 155.
19. Lee S. H., Oe T. Blair I. A. (2001) Vitamin C-induced decomposition of lipid hydroperoxides to endogenous genotoxins. Science 292, 2083 2086.
20. Lin D., Lee H. G., Liu Q., Perry G., Smith M. A. Sayre L. M. (2005) 4-Oxo-2-nonenal is both more neurotoxic and more protein reactive than 4-hydroxy-2-nonenal. Chem. Res. Toxicol. 18, 1219 1231.
21. Liu Z., Minkler P. E. Sayre L. M. (2003) Mass spectroscopic characterization of protein modification by 4-hydroxy-2-(E)-nonenal and 4-oxo-2-(E)-nonenal. Chem. Res. Toxicol. 16, 901 911.
22. Marnett L. J., Riggins J. N. West J. D. (2003) Endogenous generation of reactive oxidants and electrophiles and their reactions with DNA and protein. J. Clin. Invest. 111, 583 593.
23. Nadkarni D. V. Sayre L. M. (1995) Structural definition of early lysine and histidine adduction chemistry of 4-hydroxynonenal. Chem. Res. Toxicol. 8, 284 291.
24. Parola M., Robino G., Marra F. et al. (1998) HNE interacts directly with JNK isoforms in human hepatic stellate cells. J. Clin. Invest. 102, 1942 1950.
25. Poli G., Leonarduzzi G., Biasi F. Chiarpotto E. (2004) Oxidative stress and cell signalling. Curr. Med. Chem. 11, 1163 1182.
26. Pollack M., Yang I. Y., Kim H. Y., Blair I. A. Moriya M. (2006) Translesion DNA Synthesis across the heptanone - etheno-2′-deoxycytidine adduct in cells. Chem. Res. Toxicol. 19, 1074 1079.
27. Ridnour L. A., Isenberg J. S., Espey M. G., Thomas D. D., Roberts D. D. Wink D. A. (2005) Nitric oxide regulates angiogenesis through a functional switch involving thrombospondin-1. Proc. Natl Acad. Sci. USA 102, 13147 13152.
28. Sampey B. P., Carbone D. L., Doorn J. A., Drechsel D. A. Petersen D. R. (2007) 4-Hydroxy-2-nonenal adduction of extracellular signal-regulated kinase (Erk) and the inhibition of hepatocyte Erk-Est-like protein-1-activating protein-1 signal transduction. Mol. Pharmacol. 71, 871 883.
29. Sayre L. M., Zelasko D. A., Harris P. L., Perry G., Salomon R. G. Smith M. A. (1997) 4-Hydroxynonenal-derived advanced lipid peroxidation end products are increased in Alzheimer's disease. J. Neurochem. 68, 2092 2097.
30. Sayre L. M., Smith M. A. Perry G. (2001) Chemistry and biochemistry of oxidative stress in neurodegenerative disease. Curr. Med. Chem. 8, 721 738.
31. Sayre L. M., Lin D., Yuan Q., Zhu X. Tang X. (2006) Protein adducts generated from products of lipid oxidation: focus on HNE and one. Drug Metab. Rev. 38, 651 675.
32. Shibata T., Iio K., Kawai Y., Shibata N., Kawaguchi M., Toi S., Kobayashi M., Yamamoto K. Uchida K. (2006) Identification of a lipid peroxidation product as a potential trigger of the p53 pathway. J. Biol. Chem. 281, 1196 1204.
33. Shieh S. Y., Ikeda M., Taya Y. Prives C. (1997) DNA damage-induced phosphorylation of p53 alleviates inhibition by MDM2. Cell 91, 325 334.
34. Siliciano J. D., Canman C. E., Taya Y., Sakaguchi K., Appella E. Kastan M. B. (1997) DNA damage induces phosphorylation of the amino terminus of p53. Genes Dev. 11, 3471 3481.
35. Song B. J., Soh Y., Bae M., Pie J., Wan J. Jeong K. (2001) Apoptosis of PC12 cells by 4-hydroxy-2-nonenal is mediated through selective activation of the c-Jun N-terminal protein kinase pathway. Chem. Biol. Interact. 130-132, 943 954.
36. Stanciu M., Wang Y., Kentor R. et al. (2000) Persistent activation of ERK contributes to glutamate-induced oxidative toxicity in a neuronal cell line and primary cortical neuron cultures. J. Biol. Chem. 275, 12200 12206.
37. Takeda A., Smith M. A., Avila J., Nunomura A., Siedlak S. L., Zhu X., Perry G. Sayre L. M. (2000) In Alzheimer's disease, heme oxygenase is coincident with Alz50, an epitope of tau induced by 4-hydroxy-2-nonenal modification. J. Neurochem. 75, 1234 1241.
38. Tamagno E., Parola M., Bardini P. et al. (2005) Beta-site APP cleaving enzyme up-regulation induced by 4-hydroxynonenal is mediated by stress-activated protein kinases pathways. J. Neurochem. 92, 628 636.
39. Uchida K., Shiraishi M., Naito Y., Torii Y., Nakamura Y. Osawa T. (1999) Activation of stress signaling pathways by the end product of lipid peroxidation. 4-hydroxy-2-nonenal is a potential inducer of intracellular peroxide production. J. Biol. Chem. 274, 2234 2242.
40. Unger T., Sionov R. V., Moallem E., Yee C. L., Howley P. M., Oren M. Haupt Y. (1999) Mutations in serines 15 and 20 of human p53 impair its apoptotic activity. Oncogene 18, 3205 3212.
41. Wang X., Martindale J. L., Liu Y. Holbrook N. J. (1998) The cellular response to oxidative stress: influences of mitogen-activated protein kinase signalling pathways on cell survival. Biochem. J. 333, 291 300.
42. West J. D., Ji C., Duncan S. T., Amarnath V., Schneider C., Rizzo C. J., Brash A. R. Marnett L. J. (2004) Induction of apoptosis in colorectal carcinoma cells treated with 4-hydroxy-2-nonenal and structurally related aldehydic products of lipid peroxidation. Chem. Res. Toxicol. 17, 453 462.
43. Xia Z., Dickens M., Raingeaud J., Davis R. J. Greenberg M. E. (1995) Opposing effects of ERK and JNK-p38 MAP kinases on apoptosis. Science 270, 1326 1331.
44. Yoritaka A., Hattori N., Uchida K., Tanaka M., Stadtman E. R. Mizuno Y. (1996) Immunohistochemical detection of 4-hydroxynonenal protein adducts in Parkinson disease. Proc. Natl Acad. Sci. USA 93, 2696 2701.
45. Zhang W. H., Liu J., Xu G., Yuan Q. Sayre L. M. (2003) Model studies on protein side chain modification by 4-oxo-2-nonenal. Chem. Res. Toxicol. 16, 512 523.
46. Zhu X. Sayre L. M. (2007) Mass spectrometric evidence for long-lived protein adducts of 4-oxo-2-nonenal. Redox Rep. 12, 45 49.
47. Zhuang S., Yan Y., Daubert R. A., Han J. Schnellmann R. G. (2007) ERK promotes hydrogen peroxide-induced apoptosis through caspase-3 activation and inhibition of Akt in renal epithelial cells. Am. J. Physiol. Renal. Physiol. 292, F440 F447.